Prep

Truvada, the first pre-exposure prophylaxis (PrEP) medication approved by the Food and Drug Administration that reduces the risk of infection in uninfected people who have sex with HIV-infected partners, isn’t being as widely used as it should be. This is in spite of studies that show the therapy is nearly 100 percent effective. “I see […]

HIV infection rates among young Black gay men are increasing at alarming rates and implicit bias may be fueling it.